{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:28:07Z","timestamp":1757543287835},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jcardioanesthesia.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1053\/j.jvca.2017.04.046","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T16:31:41Z","timestamp":1493224301000},"page":"1857-1864","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Perioperative Management of Dual-Antiplatelet Therapy in Patients With New-Generation Drug-Eluting Metallic Stents and Bioresorbable Vascular Scaffolds Undergoing Elective Noncardiac Surgery"],"prefix":"10.1053","volume":"31","author":[{"given":"Michael","family":"Essandoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam A.","family":"Dalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen","family":"Albaghdadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoleta","family":"Stoicea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Shabsigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil V.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2017.04.046_bib1","first-page":"93","article-title":"Prevention of stent thrombosis: Challenges and solutions","volume":"11","author":"Reejhsinghani","year":"2015","journal-title":"Vasc Health Risk Manag"},{"key":"10.1053\/j.jvca.2017.04.046_bib2","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jtcvs.2016.07.044","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"152","author":"Levine","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2017.04.046_bib3","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/eht517","volume":"35","author":"Kolh","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2017.04.046_bib4","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.jacc.2012.08.966","article-title":"A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: A report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011","volume":"60","author":"Dehmer","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2017.04.046_bib5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jcin.2010.03.021","article-title":"Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry","volume":"3","author":"Berger","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.jvca.2017.04.046_bib6","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/CIRCULATIONAHA.112.102715","article-title":"Risk of elective major noncardiac surgery after coronary stent insertion: A population-based study","volume":"126","author":"Wijeysundera","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2017.04.046_bib7","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/ccd.22744","article-title":"Frequency and risk of noncardiac surgery after drug-eluting stent implantation","volume":"77","author":"Gandhi","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1053\/j.jvca.2017.04.046_bib8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jamcollsurg.2011.12.011","article-title":"The incidence and timing of noncardiac surgery after cardiac stent implantation","volume":"214","author":"Hawn","year":"2012","journal-title":"J Am Coll Surg"},{"key":"10.1053\/j.jvca.2017.04.046_bib9","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.jacc.2016.09.967","article-title":"Risk associated with surgery within 12 months after coronary drug-eluting stent implantation","volume":"68","author":"Egholm","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2017.04.046_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCULATIONAHA.111.059022","article-title":"Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: The Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study","volume":"125","author":"Gwon","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2017.04.046_bib11","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/jama.2013.278787","article-title":"Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents","volume":"310","author":"Hawn","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2017.04.046_bib12","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/eurheartj\/ehu523","article-title":"ISAR-SAFE: A randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting","volume":"36","author":"Schulz-Schupke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2017.04.046_bib13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijcard.2016.01.068","volume":"207","author":"Tarantini","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1053\/j.jvca.2017.04.046_bib14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3928\/01477447-20120725-06","article-title":"Perioperative management of antiplatelet agents","volume":"35","author":"Mohr","year":"2012","journal-title":"Orthopedics"},{"key":"10.1053\/j.jvca.2017.04.046_bib15","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1053\/j.jvca.2016.03.157","article-title":"CASE 11-2016 Perioperative coronary thrombosis in a patient with multiple second-generation drug-eluting stents: Is it time for a paradigm shift?","volume":"30","author":"Essandoh","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2017.04.046_bib16","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.jacc.2014.09.008","article-title":"Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: The SECURITY randomized clinical trial","volume":"64","author":"Colombo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2017.04.046_bib17","first-page":"2510","article-title":"Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: The OPTIMIZE randomized trial","volume":"310","author":"Feres","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2017.04.046_bib18","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: The RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2017.04.046_bib19","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.111.071589","article-title":"Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial","volume":"125","author":"Valgimigli","year":"2012","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2017.04.046_bib20","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMoa1001266","article-title":"Duration of dual antiplatelet therapy after implantation of drug-eluting stents","volume":"362","author":"Park","year":"2010","journal-title":"N Eng J Med"},{"key":"10.1053\/j.jvca.2017.04.046_bib21","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(14)60612-7","article-title":"Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): A randomised trial","volume":"384","author":"Collet","year":"2014","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2017.04.046_bib22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jacc.2014.11.008","article-title":"6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: The randomized, multicenter ITALIC trial","volume":"65","author":"Gilard","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2017.04.046_bib23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.113.003303","article-title":"Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: A randomized, controlled trial","volume":"129","author":"Lee","year":"2014","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2017.04.046_bib24","first-page":"365","article-title":"Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: The OPTIDUAL randomized trial","volume":"37","author":"Helft","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1053\/j.jvca.2017.04.046_bib25","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.04.046_bib26","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.04.046_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12471-015-0651-3","article-title":"Appropriate use of bioresorbable vascular scaffolds in percutaneous coronary interventions: A recommendation from experienced users: A position statement on the use of bioresorbable vascular scaffolds in the Netherlands","volume":"23","author":"Everaert","year":"2015","journal-title":"Neth Heart J"},{"key":"10.1053\/j.jvca.2017.04.046_bib28","doi-asserted-by":"crossref","first-page":"f6530","DOI":"10.1136\/bmj.f6530","article-title":"Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: Comprehensive network meta-analysis","volume":"347","author":"Navarese","year":"2013","journal-title":"BMJ"},{"key":"10.1053\/j.jvca.2017.04.046_bib29","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jacc.2015.12.019","article-title":"Bioresorbable coronary scaffold thrombosis","volume":"67","author":"Puricel","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/j.jvca.2017.04.046_bib30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: A meta-analysis of randomised controlled trials","volume":"387","author":"Cassese","year":"2016","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2017.04.046_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcin.2016.10.027","article-title":"Very late scaffold thrombosis of bioresorbable vascular scaffold: Systematic review and a meta-analysis","volume":"10","author":"Toyota","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"1 Pt B","key":"10.1053\/j.jvca.2017.04.046_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcin.2014.10.005","volume":"8","author":"Brugaletta","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.jvca.2017.04.046_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcin.2016.10.019","article-title":"Efficacy and safety of the Absorb everolimus-eluting bioresorbable scaffold for treatment of patients with diabetes mellitus: Results of the Absorb diabetic substudy","volume":"10","author":"Kereiakes","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1053\/j.jvca.2017.04.046_bib34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/bja\/aep373","article-title":"Urgent surgery in patients with a recently implanted coronary drug-eluting stent: A phase II study of \u2018bridging\u2019 antiplatelet therapy with tirofiban during temporary withdrawal of clopidogrel","volume":"104","author":"Savonitto","year":"2010","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2017.04.046_bib35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/10245330701554623","article-title":"Alterations of hemostasis after laparoscopic and open surgery","volume":"12","author":"Diamantis","year":"2007","journal-title":"Hematology"},{"key":"10.1053\/j.jvca.2017.04.046_bib36","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1111\/j.1538-7836.2007.02694.x","article-title":"Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery","volume":"5","author":"Rajagopalan","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.jvca.2017.04.046_bib37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: A randomized controlled trial","volume":"307","author":"Angiolillo","year":"2012","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2017.04.046_bib38","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1213\/ANE.0b013e318203f38d","article-title":"Antiplatelet drugs: A review of their pharmacology and management in the perioperative period","volume":"112","author":"Hall","year":"2011","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2017.04.046_bib39","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/HPC.0000000000000084","article-title":"Bridging experience with eptifibatide after stent implantation","volume":"15","author":"Barra","year":"2016","journal-title":"Crit Pathw Cardiol"},{"key":"10.1053\/j.jvca.2017.04.046_bib40","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4244\/EIJV9I2A35","article-title":"Outcomes of a preoperative \u201cbridging\u201d strategy with glycoprotein IIb\/IIIa inhibitors to prevent perioperative stent thrombosis in patients with drug-eluting stents who undergo surgery necessitating interruption of thienopyridine administration","volume":"9","author":"Alshawabkeh","year":"2013","journal-title":"EuroIntervention"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077017304706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077017304706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T09:57:41Z","timestamp":1535882261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077017304706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1053077017304706"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2017.04.046","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative Management of Dual-Antiplatelet Therapy in Patients With New-Generation Drug-Eluting Metallic Stents and Bioresorbable Vascular Scaffolds Undergoing Elective Noncardiac Surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2017.04.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}